Insider Stock Trading History of Palombella Vito J.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Palombella Vito J. since year 2005. The trader's CIK number is 1492805. At the time of this reporting, Palombella Vito J. is the Chief Scientific Officer of Infinity Pharmaceuticals, Inc. . (stock ticker symbol INFI). See this page for all insider trading activities at Infinity Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Palombella Vito J. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-06-15 INFI Infinity Pharmaceuticals, Inc. Sale 4,737 10.97 51,964
2015-04-30 INFI Infinity Pharmaceuticals, Inc. Option Ex 4,737 2.04 9,663
2014-12-15 INFI Infinity Pharmaceuticals, Inc. Option Ex 4,737 2.04 9,663
2014-12-15 INFI Infinity Pharmaceuticals, Inc. Sale 4,737 16.32 77,293
2014-11-26 INFI Infinity Pharmaceuticals, Inc. Option Ex 4,736 2.04 9,661
2014-11-26 INFI Infinity Pharmaceuticals, Inc. Sale 4,736 15.00 71,040
2014-09-03 INFI Infinity Pharmaceuticals, Inc. Option Ex 9,472 2.04 19,322
2014-09-03 INFI Infinity Pharmaceuticals, Inc. Sale 9,472 15.39 145,774
2014-07-01 INFI Infinity Pharmaceuticals, Inc. Sale 879 12.87 11,312
2014-02-25 INFI Infinity Pharmaceuticals, Inc. Sale 4,736 15.00 71,040
2014-02-25 INFI Infinity Pharmaceuticals, Inc. Option Ex 4,736 2.04 9,661
2014-01-02 INFI Infinity Pharmaceuticals, Inc. Sale 753 13.52 10,180
2013-09-27 INFI Infinity Pharmaceuticals, Inc. Option Ex 4,736 2.04 9,661
2013-09-27 INFI Infinity Pharmaceuticals, Inc. Sale 4,736 17.28 81,838
2013-06-20 INFI Infinity Pharmaceuticals, Inc. Option Ex 22,103 1.72 38,017
2013-06-20 INFI Infinity Pharmaceuticals, Inc. Sale 23,150 18.53 429,062

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Palombella Vito J. (Chief Scientific Officer of Infinity Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.